Skip to main navigation

Home
Technology
- Product Details
- HIFU Technology
Physicians
- Prostate Cancer Management
- Clinical Information
Patients
Company

Menu

Home
Technology
- Product Details
- HIFU Technology
Physicians
- Prostate Cancer Management
- Clinical Information
Patients
Company

FocalTherics™ - Investor Relations

Quarterly Results

Investor Relations

Overview
News & Events
- News
- Events & Presentations
Financial Information
Stock Information
Corporate Governance
Investor Resources
- Contact Us
- Email Alerts

Show all

2026

Q1

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

2025

Q4

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

Q3

EDAP Reports Third Quarter 2025 Financial Results

Q2

EDAP Reports Strong Second Quarter 2025 HIFU Results

Q1

EDAP Reports First Quarter 2025 Financial Results

2024

Q4

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Q3

EDAP Reports Third Quarter 2024 Financial Results

Q2

EDAP Reports Second Quarter 2024 Financial Results

Q1

EDAP Reports First Quarter 2024 Financial Results

2023

Q4

EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results

Q3

EDAP Announces Third Quarter 2023 Financial Results

Q2

EDAP Announces Second Quarter 2023 Financial Results

Q1

EDAP Announces First Quarter 2023 Financial Results

2022

Q4

EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy

Q3

EDAP Reports Third Quarter 2022 Results

Q2

EDAP Reports Second Quarter 2022 Results

Q1

EDAP Reports First Quarter 2022 Results

2021

Q4

EDAP Reports Fourth Quarter and Full Year 2021 Results

Q3

EDAP Reports Third Quarter 2021 Results and Provides Operational Update

Q2

EDAP Reports Second Quarter 2021 Results and Provides Operational Update

Q1

EDAP Reports First Quarter 2021 Results and Provides Operational Update

2020

Q4

EDAP Fourth Quarter and Fiscal Year 2020 Financial Results
EDAP TMS SA to Announce Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021

Q3

EDAP Third Quarter 2020 Financial Results
EDAP Reports Third Quarter 2020 Results and Provides Operational Update

Q2

EDAP Second Quarter 2020 Financial Results
EDAP Reports Second Quarter 2020 Results and Provides Operational Update

Q1

EDAP First Quarter 2020 Financial Results
EDAP Reports First Quarter 2020 Results and Provides Operational Update

2019

Q4

EDAP Fourth Quarter and Fiscal Year 2019 Financial Results
EDAP Reports Record Full Year 2019 Results and Provides Operational Update

Q3

EDAP Third Quarter 2019 Financial Results
EDAP Reports 2019 Third Quarter and Nine Months Results

Q2

EDAP Second Quarter 2019 Financial Results
EDAP Reports 2019 Second Quarter Results

Q1

EDAP First Quarter 2019 Financial Results
EDAP Reports 2019 First Quarter Results

2018

Q4

EDAP Fourth Quarter and Fiscal Year 2018 Financial Results
EDAP Reports Q4 and Full Year 2018 Results

Q3

EDAP Third Quarter 2018 Financial Results
EDAP TMS SA : EDAP Reports 2018 Third Quarter Results

Q2

EDAP Second Quarter 2018 Financial Results
EDAP TMS SA : EDAP Reports 2018 Second Quarter Results

Q1

EDAP First Quarter 2018 Financial Results
EDAP TMS SA : EDAP Reports 2018 First Quarter Results

2017

Q4

EDAP Fourth Quarter 2017 Results Conference Call

Q3

EDAP Third Quarter 2017 Results Conference Call
EDAP TMS Reports Third Quarter 2017 Results

2016

Q4

EDAP Achieves 63% Growth in HIFU Revenue in 2016
EDAP Fourth Quarter 2016 and Annual Results Conference Call

Q3

EDAP Third Quarter 2016 Results Conference Call
EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016

Q2

EDAP Second Quarter 2016 Results Conference Call
EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016

Q1

EDAP First Quarter 2016 Results Conference Call
EDAP First Quarter 2016 Revenue Increases 40% Year-over-Year to &amp;#8364;8.7 Million

2015

Q4

EDAP Fourth Quarter 2015 Results Conference Call
EDAP Reports 20% Revenue Growth to EUR 32.3 Million and EUR 0.5 Million Operating Profit for Full-year 2015

Q3

EDAP Reports Third Quarter 2015 Financial Results and Operational Update
EDAP Third Quarter 2015 Results Conference Call

Q2

EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015
EDAP Second Quarter 2015 Results Conference Call

Q1

EDAP Reports First Quarter 2015 Results
EDAP First Quarter 2015 Results Conference Call

2014

Q4

EDAP Reports Fourth Quarter and Full Year 2014 Results
EDAP Fourth Quarter 2014 Results Conference Call

Q3

EDAP Reports Continued Strong Growth in Third Quarter 2014
EDAP Third Quarter 2014 Results Conference Call

Q2

EDAP Reports Strong Growth in Its Second Quarter 2014 Results

Q1

EDAP Reports First Quarter 2014 Results

2013

Q4

EDAP Reports Fourth Quarter 2013 and Full Year Results
EDAP Fourth Quarter and Full Year 2013 Results Conference Call

Q3

EDAP Reports Third Quarter 2013 Results

Q2

EDAP Reports Second Quarter 2013 Results

Q1

EDAP Announces 23% First Quarter 2013 Revenue Growth

2012

Q4

EDAP Reports Fourth Quarter 2012 and Full Year Results

Q3

EDAP Reports Third Quarter 2012 Results

Q2

EDAP Reports Second Quarter 2012 Revenues Up 61%

Q1

EDAP Reports First Quarter 2012 Financial Results

2011

Q4

EDAP Reports Fourth Quarter Revenue Up 23% Sequentially

Q3

EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results

Q2

EDAP Reports Second Quarter 2011 Financial Results

Q1

EDAP Reports First Quarter 2011 Financial Results

2010

Q4

EDAP Reports Fourth Quarter and Full Year 2010 Financial Results

Q3

EDAP Reports Third Quarter 2010 Financial Results

Q2

EDAP Reports Second Quarter 2010 Financial Results

Q1

EDAP Reports First Quarter 2010 Financial Results

2009

Q4

EDAP Reports Record Full Year 2009 Financial Results

Q3

EDAP Reports Third Quarter 2009 Financial Results

Q2

EDAP Reports Second Quarter 2009 Financial Results

Q1

EDAP Reports First Quarter 2009 Financial Results

2008

Q4

EDAP Reports Fourth Quarter and Full Year 2008 Financial Results

Q3

EDAP Reports Third Quarter 2008 Financial Results

Q2

EDAP Reports Second Quarter 2008 Financial Results

Q1

EDAP Reports First Quarter 2008 Financial Results<br>

2007

Q4

EDAP Reports Fourth Quarter and Full Year 2007 Financial Results

Q3

EDAP TMS S.A. 2007 Third Quarter HIFU Revenues Increase

Investor Contact

Louisa Smith

Gilmartin Group

investor.relations@focalone.com

EDAP TMS SA

investor.relations@focalone.com

Get Updates And Stay Connected

Get New Updates Directly To Your Inbox.

Email Address* Required

Focal One® - HIFU Prostate Tissue Ablation

Focal One^® has received regulatory clearance and is marketed in the United States, Europe, Canada, Korea, Russia, Brazil and other countries. In the United States, Focal One^® is indicated for the ablation of prostate tissue. Focal One^® is a registered trademark of EDAP TMS.

Discover More

FocalTherics Information

P: +1(512) 832-7956
E: investor.relations@focalone.com
A: 4410 El Camino Real, # 150,
Los Altos, CA 94022

EDAP TMS S.A., the issuer of record for the Company's publicly traded securities, is evolving its corporate brand to FocalTherics to better reflect its focused therapeutic ultrasound strategy and long-term growth vision. While the Company will continue to operate under its legal name, EDAP TMS S.A., it now does business as FocalTherics across its investor and corporate communications. This brand transition aligns the Company's identity with its expanding innovation portfolio while maintaining continuity, transparency, and regulatory compliance for shareholders. All historical filings, disclosures, and governance materials remain attributable to EDAP TMS S.A., ensuring clarity and consistency throughout this evolution.